References

  1. Terézhalmy GT, Huber MA, Jones AC. Physical evaluation in dental practice, 1st ed. Ames, IA. Wiley-Blackwell. 2009.
  2. About the DrugsStats database. Drug usage statistics for the United States. ClinCalc.com. Accessed November 15, 2017.
  3. NIH. U.S. National Library of Medicine. DailyMed. Advanced Search. Accessed November 15, 2017.
  4. Galanter JM, Cornes SB, Lowenstein DH. Principles of nervous system physiology and pharmacology. Principles of Pharmacology: The pathophysiologic basis of drug therapy, 4th ed. David E. Golan (Ed). Philadelphia, PA. Wolters Kluwer. 2017:110-25.
  5. Mayne E Buhl LK, Strichartz GR. Principles of cellular excitability and electrochemical transmission. Principles of Pharmacology: The pathophysiologic basis of drug therapy, 4th ed. David E. Golan (Ed). Philadelphia, PA. Wolters Kluwer. 2017:98-109.
  6. Forman SA, Feng HJ, Chou J, Mao J, Lo EH. Pharmacology of GABAergic and glutamatergic neurotransmission. Principles of Pharmacology: The pathophysiologic basis of drug therapy, 4th ed. David E. Golan (Ed). Philadelphia, PA. Wolters Kluwer. 2017:184-205.
  7. Standaert GD, Sung VW. Pharmacology of dopaminergic neurotransmission. Principles of Pharmacology: The pathophysiologic basis of drug therapy, 4th ed. David E. Golan (Ed). Philadelphia, PA. Wolters Kluwer. 2017:206-25.
  8. Atri A, Chang MS, Strichatrz GR. Cholinergic pharmacology. Principles of Pharmacology: The pathophysiologic basis of drug therapy, 4th ed. David E. Golan (Ed). Philadelphia, PA. Wolters Kluwer. 2017:127-49.
  9. Haggarty SJ, Perlis RH. Pharmacology of serotonergic and central adrenergic neurotransmission. Principles of Pharmacology: The pathophysiologic basis of drug therapy, 4th ed. David E. Golan (Ed). Philadelphia, PA. Wolters Kluwer. 2017:227-48.
  10. Gera N, Armstrong EJ, Golan DE. Adrenergic pharmacology. Principles of Pharmacology: The pathophysiologic basis of drug therapy, 4th ed. David E. Golan (Ed). Philadelphia, PA. Wolters Kluwer. 2017:150-66.
  11. Cornes SB, Griffin Jr. EA, Lowenstein DH. Pharmacology of abnormal electrical neurotransmission in the central nervous system. Principles of Pharmacology: The pathophysiologic basis of drug therapy, 4th ed. David E. Golan (Ed). Philadelphia, PA. Wolters Kluwer. 2017:249-64.
  12. Charney DS, Drevets WC. Neurobiological basis of anxiety disorders. Accessed November 15, 2017.
  13. Locke AB, Kirst N, Shultz CG. Diagnosis and management of generalized anxiety disorder and panic disorder in adults. Am Fam Physician. 2015 May 1;91(9):617-24.
  14. Grist JH, Jefferson JW. Generalized anxiety disorder. The Merck manual of diagnosis and therapy, 19th ed. Robert S. Porter (Ed). Whitehouse station, NJ. Merck Sharp & Dohme Corp. 2011:1494-95.
  15. Maurer DM. Screening for depression. Am Fam Physician. 2012 Jan 15;85(2):139-44.
  16. Price AL, Marzani-Nissen GR. Bipolar disorders: a review. Am Fam Physician. 2012 Mar 1;85(5):483-93.
  17. Coryell W. Mood disorders. The Merck manual of diagnosis and therapy, 19th ed. Robert S. Porter (Ed). Whitehouse station, NJ. Merck Sharp & Dohme Corp. 2011:1538-52.
  18. Holder SD, Wayhs A. Schizophrenia. Am Fam Physician. 2014 Dec 1;90(11):775-82.
  19. Bustillo JR. Schizophrenia and related disorders. The Merck manual of diagnosis and therapy, 19th ed. Robert S. Porter (Ed). Whitehouse station, NJ. Merck Sharp & Dohme Corp. 2011:1559-67.
  20. Vélez L, Selwa LM. Seizure disorders in the elderly. Am Fam Physician. 2003 Jan 15;67(2):325-32.
  21. Adamolekun B. Seizure disorders. The Merck manual of diagnosis and therapy, 19th ed. Robert S. Porter (Ed). Whitehouse station, NJ. Merck Sharp & Dohme Corp. 2011:1686-1702.
  22. Gitto CA, Moroni MJ, Terezhalmy GT, et al. The patient with Alzheimer's disease. Quintessence Int. 2001 Mar;32(3):221-31.
  23. Winslow BT, Onysko MK, Stob CM, et al. Treatment of Alzheimer disease. Am Fam Physician. 2011 Jun 15;83(12):1403-12.
  24. Auchus A. Alzheimer’s disease. The Merck manual of diagnosis and therapy, 19th ed. Robert S. Porter (Ed). Whitehouse station, NJ. Merck Sharp & Dohme Corp. 2011:1677-80.
  25. Dirks SJ, Paunovich ED, Terezhalmy GT, et al. The patient with Parkinson's disease. Quintessence Int. 2003 May;34(5):379-93.
  26. Rao SS, Hofmann LA, Shakil A. Parkinson's disease: diagnosis and treatment. Am Fam Physician. 2006 Dec 15;74(12):2046-54.
  27. Gazewood JD, Richards DR, Clebak K. Parkinson disease: an update. Am Fam Physician. 2013 Feb 15;87(4):267-73.
  28. Eidelberg D, Pourfar M. Parkinson’s disease. The Merck manual of diagnosis and therapy, 19th ed. Robert S. Porter (Ed). Whitehouse station, NJ. Merck Sharp & Dohme Corp. 2011:1765-70.
  29. Felt BT, Biermann B, Christner JG, et al. Diagnosis and management of ADHD in children. Am Fam Physician. 2014 Oct 1;90(7):456-64.
  30. Post RE, Kurlansik SL. Diagnosis and management of adult attention-deficit/hyperactivity disorder. Am Fam Physician. 2012 May 1;85(9):890-6.
  31. Bimstein E, Wilson J, Guelmann M, et al. Oral characteristics of children with attention-deficit hyperactivity disorder. Spec Care Dentist. 2008 May-Jun;28(3):107-10. doi: 10.1111/j.1754-4505.2008.00021.x.
  32. Blomqvist M, Holmberg K, Fernell E, et al. Oral health, dental anxiety, and behavior management problems in children with attention deficit hyperactivity disorder. Eur J Oral Sci. 2006 Oct;114(5):385-90.
  33. Friedlander AH, Yagiela JA, Mahler ME, et al. The pathophysiology, medical management and dental implications of adult attention-deficit/hyperactivity disorder. J Am Dent Assoc. 2007 Apr;138(4):475-82; quiz 535, 537.
  34. Sulkes SB. Attention-deficit/hyperactivity disorder. The Merck manual of diagnosis and therapy, 19th ed. Robert S. Porter (Ed). Whitehouse station, NJ. Merck Sharp & Dohme Corp. 2011:13035-38.

Additional Resources

  • No Additional Resources Available